Michael Gramlich

Dr. Michael Gramlich


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
MGMichael Gramlich
Michael Gramlich
LPLuna Simona Pane
Luna Simona Pane
QZQifeng Zhou
Qifeng Zhou
ZCZhifen Chen
Zhifen Chen
MMMarta Murgia
Marta Murgia
AMAlessandra Moretti
Alessandra Moretti
Frameshift mutations in the TTN gene encoding titin are a major cause for inherited forms of dilated cardiomyopathy (DCM), a heart disease characterized by ventricular dilatation, systolic dysfunction, and progressive heart failure. To date, there are no specific treatment options for DCM patients but heart transplantation. Here, we show the beneficial potential of reframing titin transcripts by antisense oligonucleotide (AON)‐mediated exon skipping in human and murine models of DCM carrying a previously identified autosomal‐dominant frameshift mutation in titin exon 326. Correction of TTN reading frame in patient‐specific cardiomyocytes derived from induced pluripotent stem cells rescued defective myofibril assembly and stability and normalized the sarcomeric protein expression. AON treatment in Ttn knock‐in mice improved sarcomere formation and contractile performance in homozygous embryos and prevented the development of the DCM phenotype in heterozygous animals. These results demonstrate that disruption of the titin reading frame due to a truncating DCM mutation can be restored by exon skipping in both patient cardiomyocytes in vitro and mouse heart in vivo , indicating RNA‐based strategies as a potential treatment option for DCM.

1 March 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
QZQifeng Zhou
Qifeng Zhou
SSSonja Schötterl
Sonja Schötterl
DBDaniel Backes
Daniel Backes
EBEva Brunner
Eva Brunner
JHJulia Kelley Hahn
Julia Kelley Hahn
MGMichael Gramlich
Michael Gramlich

Verified
Journal Article
Open access
PDF file
QZQifeng Zhou
Qifeng Zhou
JHJulia Kelley Hahn
Julia Kelley Hahn
BNBalram Neupane
Balram Neupane
PAParwez Aidery
Parwez Aidery
SLSiegfried Labeit
Siegfried Labeit
MGMichael Gramlich
Michael Gramlich
Apoptosis (type I programmed cell death) of cardiomyocytes is a major process that plays a role in the progression of heart failure. The early response gene IER3 regulates apoptosis in a wide variety of cells and organs. However, its role in heart failure is largely unknown. Here, we investigate the role of IER3 in an inducible heart failure mouse model. Heart failure was induced in a mouse model that imitates a human titin truncation mutation we found in a patient with dilated cardiomyopathy (DCM). Transferase dUTP nick end labeling (TUNEL) and ssDNA stainings showed induction of apoptosis in titin-deficient cardiomyocytes during heart failure development, while IER3 response was dysregulated. Chromatin immunoprecipitation and knock-down experiments revealed that IER3 proteins target the promotors of anti-apoptotic genes and act as an anti-apoptotic factor in cardiomyocytes. Its expression is blunted during heart failure development in a titin-deficient mouse model. Targeting the IER3 pathway to reduce cardiac apoptosis might be an effective therapeutic strategy to combat heart failure.

4 October 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QZQifeng Zhou
Qifeng Zhou
SKScott Kesteven
Scott Kesteven
JWJianxin Wu
Jianxin Wu
PAParwez Aidery
Parwez Aidery
MGMeinrad Gawaz
Meinrad Gawaz
RHRichard P. Harvey
Richard P. Harvey
Mutations in the giant sarcomeric protein titin (TTN) are a major cause for inherited forms of dilated cardiomyopathy (DCM). We have previously developed a mouse model that imitates a TTN truncation mutation we found in a large pedigree with DCM. While heterozygousTtnknock-in mice do not display signs of heart failure under sedentary conditions, they recapitulate the human phenotype when exposed to the pharmacological stressor angiotensin II or isoproterenol. In this study we investigated the effects of pressure overload by transverse aortic constriction (TAC) in heterozygous (Het)Ttnknock-in mice. Two weeks after TAC, Het mice developed marked impairment of left ventricular ejection fraction(p<0.05), while wild-type (WT) TAC mice did not. Het mice also trended toward increased ventricular end diastolic pressure and volume compared to WT littermates. We found an increase in histologically diffuse cardiac fibrosis in Het compared to WT in TAC mice. This study shows that a pattern of DCM can be induced by TAC-mediated pressure overload in a TTN-truncated mouse model. This model enlarges our arsenal of cardiac disease models, adding a valuable tool to understand cardiac pathophysiological remodeling processes and to develop therapeutic approaches to combat heart failure.

2 February 2018 in Personalized Medicine
Verified
Journal Article
Closed access
BNBalram Neupane
Balram Neupane
QZQifeng Zhou
Qifeng Zhou
MGMeinrad Gawaz
Meinrad Gawaz
MGMichael Gramlich
Michael Gramlich
Inflammatory cardiomyopathy is the result of persistent myocardial inflammation which can arise from both infectious or noninfectious causes. While most patients with acute myocarditis recover, up to 20% develop inflammatory cardiomyopathy with chronic heart failure. The interaction between host factors and factors of the agent that triggered myocardial inflammation must be considered to fully understand the individual mechanism of disease. Several inflammatory biomarkers, histology, immunohistochemistry, advanced imaging technologies as well as molecular high-throughput sequencing techniques help to identify disease pathways and to establish a comprehensive, individualized treatment approach, which can include anti-inflammatory medication, antiviral drugs and heart failure therapy. This might help to prevent transition from acute inflammation to persistent heart failure and to restore cardiac function.

31 August 2009 in Mechanisms of Development
Verified
Journal Article
Closed access
OPOwen W.J. Prall
Owen W.J. Prall
MSMargie Sunde
Margie Sunde
MCMauro Costa
Mauro Costa
OWOrit Wolstein
Orit Wolstein
CBChristine Biben
Christine Biben
RHRichard Harvey
Richard Harvey